Lupin hits new high
Tuesday, 16 September 2014
MUMBAI, Sept 15 (Business Standard): Lupin has moved higher by 5 per cent to Rs 1,422, also its new high on BSE, on media reports that the pharmaceutical major is in advanced talks to sign a blockbuster deal with Merck Serono.
As part of the deal, Lupin will manufacture Merck Serono's USD 1.5 billion worth branded mature drugs at its facilities, ET Now report suggests quoting unnamed sources.